RFA-DA-24-007 - Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Change to Application Due Date and Instruction in Section IV in RFA-DA-24-007, "Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)" | NOT-DA-23-032 | NIDA | Aug 7, 2023 | Jun 10, 2026 | DP1 |
For technical issues E-mail OER Webmaster